NIH-rejection-Xtandi-marchin-21march2023 This is an appalling decision. The worst is this quote: “practical application is evidenced by the “manufacture, practice, and operation” of the invention and the invention’s “availability to and use by the public….” This is what 35 USC 201(f)… Continue Reading
Patents, and technology Transfer WIPO Model Law for Developing Countries on Inventions, 1965. United International Bureaux for the Protection of Intellectual of Intellectual Property (B.I.R.P.I). 1965. (link) WIPO Model Law For Developing Countries on Inventions, Vol 1. Patents, 1979 WIPO… Continue Reading
(This timeline is part of a larger project at KEI regarding an evaluation of the 1971 Appendix to the Berne Convention on “SPECIAL PROVISIONS REGARDING DEVELOPING COUNTRIES.) In 1970, Charles F. Johnson wrote “The Origins of the Stockholm Protocol, 18… Continue Reading
KEI has shared this analysis of the WIPO negotiations on a broadcasting treaty with negotiators. WIPO-Broadcast-Treaty-Analysis-28Feb2023 Brief update 1: The WIPO negotiations on a broadcasting treaty began in 1997. This week, the broadcasters hope to finally get an SCCR node… Continue Reading
On Wednesday, 1 February 2023, Knowledge Ecology International (KEI) delivered this constituency statement on behalf of KEI, Health Action International, Oxfam, Public Services International, and the World Council of Churches on the following topic: “Universal Health Coverage – Reorienting health… Continue Reading
On January 10, 2023, twenty-five Members of Congress sent a letter to HHS Secretary Xavier Becerra urging him to act on the Xtandi request, and to use the Bayh-Dole Act to lower the price of Xtandi (enzalutamide) for US patients.… Continue Reading
While much attention has been focused on negotiations at the World Health Organization (WHO) on a pandemic treaty, there has been less scrutiny on WHO deliberations on proposed amendments to the International Health Regulations (2005). The reasons are two-fold: 1)… Continue Reading
On 16 November 2022, the Bureau of the Intergovernmental Negotiating Body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response (INB) released the conceptual zero draft in all six official languages… Continue Reading
Attached is a letter from 19 groups asking HHS Secretary Xavier Becerra to take action on the request that HHS use the federal government rights in patents on the prostate drug enzalutamide, marketed by Astellas under the brand name Xtandi.… Continue Reading
SecBecerra-18Nov2022-Sachs-Love-Xtandi November 18, 2022 Xavier Becerra Secretary Department of Health & Human Services Washington, DC Via Email: xavier.becerra@hhs.gov Dear Secretary Becerra: Today marks the one-year anniversary since the undersigned prostate cancer patients petitioned the Department of Health & Human Services… Continue Reading